INSMED Inc (INSM) — research page

US · us-cm-kg/NASDAQ/INSM · as of 2026-11-08

Identity and listing

The issuer is INSMED Inc, listed on NASDAQ under ticker INSM, with ISIN US4576693075 and LEI 529900Q55QAG41CCAC11. The security type is Corporate and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Virginia. The segment is not on the record. The status is listed, not halted.

The disclosure read

The record holds 183 filings in the window 2025-11-08 to 2026-11-08, across 93 filing days. The median gap between filing days is 2.0 days. The latest filing is dated 2026-11-03, and it is of type directors_dealings. Five days separate the latest filing from the record date of 2026-11-08. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days, and a latency of 5.0 days across 4359 issuers. The sector median is 63.0 filings, a cadence gap of 6.0 days, and a latency of 4.0 days across 526 issuers.

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Ernst & Young LLP, located in Iselin, New Jersey. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 26 research houses: Barclays, BMO Capital Markets, BofA Securities, Cantor, Evercore ISI, Goldman Sachs, Guggenheim Securities, H.C. Wainwright & Co., Jefferies, J.P. Morgan, Leerink Partners, Mizuho Securities, Morgan Stanley, Raymond James, RBC Capital Markets, Roth Capital Partners, Rothschild & Co., Redburn, Stifel, TD Cowen and Company, Truist Securities, UBS, Wells Fargo, William Blair, Wolfe Research and Saunders.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The record holds the issuer as sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)

10.2

https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)

10.3

https://data.sec.gov/submissions/CIK0001104506.json (identity.jurisdiction)

10.4

https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)

10.5

https://mcp.us-cm-kg.ai/events/NASDAQ/INSM (the disclosure lines)

10.6

https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)

10.7

https://www.sec.gov/Archives/edgar/data/1104506/000110450626000009/insm-20251231.htm (the auditor)

10.8

https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)

10.9

https://investor.insmed.com/analysts (coverage)

10.10

https://mcp.us-cm-kg.ai/record/NASDAQ/INSM (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US4576693075"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9dfefd4d9e7cabe9.